• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 30.90
(0.12%)
Sensex
84,562.78 84.11
( 0.10%)
Bank Nifty
58,517.55 135.60
( 0.23%)
Nifty IT
36,301.25 -378.20
( -1.03%)
Global Indices
Nasdaq
47,468.90 -806.92
(-1.67%)
Dow Jones
6,758.27 -113.65
(-1.65%)
Hang Seng
50,333.56 -948.27
(-1.85%)
Nikkei 225
9,816.37 -95.05
(-0.96%)
Forex
USD-INR
88.59 -0.09
(-0.10%)
EUR-INR
102.60 0.08
(0.08%)
GBP-INR
116.32 -0.42
(-0.36%)
JPY-INR
0.57 0.00
(-0.52%)

EQUITY - MARKET SCREENER

State Bank of India
Industry :  Banks - Public Sector
BSE Code
ISIN Demat
Book Value()
500112
INE062A01020
531.6043594
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SBIN
12.35
881108.6
EPS(TTM)
Face Value()
Div & Yield %
77.31
1
1.61
 

Welcure Drugs & Pharmaceuticals Ltd - Board Meeting Intimation for To Take On Record And Deliberate Upon The Letter Of Intent (LOI) Received From Telexcell Trade PTE LTD Singapore
Sep 04,2025
Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2025 inter alia to consider and approve To take on record and deliberate upon the Letter of Intent (LOI) received from Telexcell Trade PTE LTD Singapore for a proposed acquisition of up to 25% equity stake in Welcure Drugs & Pharmaceuticals Ltd. at an indicative price of Rs. 20 per share (a substantial premium over the prevailing market price).